¼¼°èÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå - »ê¾÷±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ÀǾàǰº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs, By End Users, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1732853
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 183 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,197,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,574,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,017,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

°æ±¸¿ë Ç×´ç´¢º´Á¦ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 180¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â¿¡´Â 259¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ ÁßÀÇ CAGRÀº 6.22%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

ÀÌ ½ÃÀåÀº ´ç´¢º´ ¼¼°è À¯º´·ü Áõ°¡¿Í ÀǾàǰ ¿¬±¸ÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ´ç´¢º´Àº Àα¸ °í·ÉÈ­, ÁÂ½Ä ¶óÀÌÇÁ ½ºÅ¸ÀÏ, °Ç°­¿¡ ÇØ·Î¿î ½Ä»ýȰ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¹ß»ýÇϸç ȯÀÚ ¼ö°¡ ¾öû³ª°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú ´Ù¾çÇϰí È¿°úÀûÀÎ °æ±¸ Ä¡·áÁ¦¿¡ ´ëÇÑ ¿ä±¸°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀå¿¡´Â ¼³Æ÷´Ò¿ì·¹¾ÆÁ¦, ºñ±¸¾Æ³ªÀ̵åÁ¦, DPP-4 ¾ïÁ¦Á¦, SGLT2 ¾ïÁ¦Á¦, GLP-1 ¼ö¿ëüÀÛ¿ëÁ¦ µî ´Ù¾çÇÑ ¾à¹° Ŭ·¡½º°¡ ÀÖÀ¸¸ç, °¢°¢ ´Ù¸¥ ¸ÞÄ¿´ÏÁòÀ¸·Î Ç÷´ç Á¶ÀýÀ» Çϰí ÀÖ½À´Ï´Ù. °æÀïÀº ¿©ÀüÈ÷ Ä¡¿­Çϰí, ´ë±â¾÷ Á¦¾à ±â¾÷ºÎÅÍ ½ÅÈï ±â¾÷±îÁö ±â¼ú Çõ½Å°ú ½ÃÀå Á¡À¯À² È®´ë¸¦ ¸ñÇ¥·Î »ï°í ÀÖ½À´Ï´Ù. ´ç´¢º´ °ü¸® ¼Ö·ç¼ÇÀÇ °³¼±¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÀÌ ¿ªµ¿ÀûÀ̰í ÇʼöÀûÀÎ °Ç°­ °ü¸® ºÐ¾ß Àü¹Ý¿¡ ´ëÇÑ ¿¬±¸¿Í ÅõÀÚ¸¦ °è¼Ó ÀÚ±ØÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 180¾ï 2,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 259¾ï 4,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 6.22%
±Þ¼ºÀå ºÎ¹® º´¿ø
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¼¼°è ´ç´¢º´ ÀÌȯÀ² Áõ°¡

ÁÖ¿ä ½ÃÀå °úÁ¦

³ôÀº °Ç°­ °ü¸® ºñ¿ë

ÁÖ¿ä ½ÃÀå µ¿Çâ

¸ÂÃãÇü ÀÇ·á Á¢±Ù¹ý

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå °í°´ÀÇ ¸ñ¼Ò¸®

Á¦5Àå ¼¼°è °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦6Àå ºÏ¹ÌÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¹ÌÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå Àü¸Á

Á¦11Àå ½ÃÀå ¿ªÇÐ

Á¦12Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦13Àå PESTEL ºÐ¼®

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå °æÀï ±¸µµ

Á¦16Àå Àü·«Àû Á¦¾È

Á¦17Àå ±â¾÷ ¼Ò°³¿Í ¸éÃ¥»çÇ×

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Oral Anti-Diabetic Drugs Market was valued at USD 18.02 Billion in 2024 and is projected to reach USD 25.94 Billion by 2030, growing at a CAGR of 6.22% during the forecast period. This market has witnessed notable growth due to the rising global prevalence of diabetes and continuous advancements in pharmaceutical research. Diabetes, driven by factors such as aging populations, sedentary lifestyles, and unhealthy diets, has created a vast and growing patient pool. As a result, the need for diverse and effective oral treatment options has surged. The market encompasses a wide array of drug classes, including Sulfonylureas, Biguanides, DPP-4 Inhibitors, SGLT2 Inhibitors, and GLP-1 Receptor Agonists, each addressing different mechanisms of glucose control. Competition remains robust, with established pharmaceutical giants and emerging companies striving for innovation and greater market share. The growing demand for improved diabetes management solutions continues to stimulate research and investment across this dynamic and essential healthcare sector.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 18.02 Billion
Market Size 2030USD 25.94 Billion
CAGR 2025-20306.22%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Key Market Drivers

Increasing Global Diabetes Prevalence

The rapidly growing incidence of diabetes globally is a key force driving the Oral Anti-Diabetic Drugs (OAD) market. According to the International Diabetes Federation (IDF), approximately 589 million adults aged 20-79 are living with diabetes in 2024, representing 11.1% of the global adult population. This number is expected to rise to 643 million by 2030 and 853 million by 2050. A 2024 Lancet study further highlights that around 828 million adults were affected by diabetes as of 2022. This sharp increase is attributed to lifestyle changes including physical inactivity, poor nutrition, and population aging. These factors significantly elevate the risk of type 2 diabetes, prompting a surge in demand for effective oral therapies. As the diabetic population grows, so does the need for accessible and reliable medications, underscoring the crucial role of oral anti-diabetic drugs in modern disease management.

Key Market Challenges

High Healthcare Costs

One of the major challenges in the Oral Anti-Diabetic Drugs market is the high cost associated with comprehensive diabetes care. This includes not only medications but also glucose monitoring devices, routine consultations, and hospitalization in case of complications. For many patients-especially in low- and middle-income countries-the affordability and accessibility of these treatments remain significant concerns. The price of oral anti-diabetic drugs forms a substantial part of diabetes-related expenditures, and for those lacking adequate insurance or financial support, these expenses can be burdensome. This economic pressure can result in reduced adherence to treatment regimens, ultimately impacting health outcomes and exacerbating disease progression. Managing these cost-related challenges is essential to ensure broader access to effective diabetes therapies.

Key Market Trends

Personalized Medicine Approaches

Personalized medicine is emerging as a transformative trend in the Oral Anti-Diabetic Drugs market. Recognizing that diabetes is a complex and heterogeneous condition, healthcare providers are moving towards customized treatment strategies tailored to each patient's genetic makeup, comorbidities, and personal preferences. Advances in genetic testing and biomarker analysis now allow for more accurate drug selection and dosing, enhancing treatment efficacy while reducing the risk of adverse effects. The shift away from a "one-size-fits-all" model is improving patient outcomes and safety. Personalized therapies are particularly valuable in complex cases where standard treatments may not deliver optimal results, making this trend a key driver of innovation and patient satisfaction in the market.

Key Market Players

Report Scope:

In this report, the Global Oral Anti-Diabetic Drugs Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oral Anti-Diabetic Drugs Market, By Drugs:

Oral Anti-Diabetic Drugs Market, By End Users:

Oral Anti-Diabetic Drugs Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oral Anti-Diabetic Drugs Market.

Available Customizations:

Global Oral Anti-Diabetic Drugs Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Oral Anti-Diabetic Drugs Market Outlook

6. North America Oral Anti-Diabetic Drugs Market Outlook

7. Europe Oral Anti-Diabetic Drugs Market Outlook

8. Asia-Pacific Oral Anti-Diabetic Drugs Market Outlook

9. South America Oral Anti-Diabetic Drugs Market Outlook

10. Middle East and Africa Oral Anti-Diabetic Drugs Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â